Meanwhile, We have found that FoxO3a interaction with c-Myc promoter and regulating metabolic genes as ACO2, LARS2, MRPL12 and PKM2 in cetuximab resistant CRC cells. This evidence concerns the gene MYC and colorectal carcinoma.